Acalanib 100 mg (Acalabrutinib)

Acalanib 100 mg (Acalabrutinib), general Calquence is a traditional drug used to treat Mantle Cell Lymphoma (MCL) who have entered at least one treatment for their cancer, or Habitual lymphocytic leukemia (CLL) or small lymphocytic carcinoma (SLL). Acalanib is manufactured by Drug International PharmaLtd. in Bangladesh.

Have to take it orally twice a day with or without food ( about 12 hours piecemeal).
Side Goods
The most common adverse responses ( prevalence rate ≥ 30) are

Anemia, neutropenia, upper respiratory tract infection, thrombocytopenia, headache, diarrhea, and cadaverous muscle pain.

The below information comes from the Internet. Please consult with a croaker for medical advice.

* Any advice on the use of the medicine is for reference only. Please consult with a croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.

error: Content is protected !!